Clinical and economic impacts of clinical pharmacists’ interventions in Iran: a systematic review
- 69 Downloads
There are many studies about Iranian clinical pharmacists’ interventions and their impacts on medication safety and cost. The aim of this study is to collect data and critically evaluate the clinical and economic effects of Iranian clinical pharmacist interventions and activities. To our best of knowledge, this research is the first review of publications about Iranian clinical pharmacists’ interventions and activities.
Six online databases, including PubMed, Scopus, Medline, Cochrane Central Register of Controlled Trials, Cochrane Database of Systemic Reviews, and Google Scholar were searched using the terms ‘“Iranian”, “clinical pharmacist”, ‘adverse drug reactions”, “medication errors”, “drug interaction”, “drug utilization evaluation”, “cost”, and “interventions” for English studies conducted in Iran and described clinical pharmacist-initiated interventions, published before December 2018. The search and extraction process followed PRISMA guidelines. Observational or retrospective studies, clinical trials, congress abstracts, and case reports or case series were excluded. The search strategy after full-text review identified 39 articles matching the eligibility criteria.
Thirty-nine articles were recruited. They included establishing pharmaceutical care in out-patient clinics and drug information centers (n = 4); prevention, detection, and management of adverse drug reactions(n = 4), designing protocols and improving drug utilization pattern(n = 16), prevention, detection, and management of medication errors (n = 11), and all clinical pharmacist services(n = 4). Most clinical pharmacist interventions and activities were regarding designing protocols, improving drug utilization pattern, as well as detection, prevention, and management of medication errors. About three-fourth (74.35%) of included studies were from either ambulatory care or in-patient settings in Tehran. The median (interquartile range) duration of intervention as well as follow-up phases was 9 (5) months.
Data of our review support the beneficial role of clinical pharmacists in the improvement of quality, safety, and efficiency of patients’ pharmaceutical care in Iran.
KeywordsClinical pharmacy Interventions Clinical and economic impacts Iran
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- 2.Jacobi J. Clinical pharmacists: practitioners who are essential members of your clinical care team. Revista Médica Clínica Las Condes. 2016;27(5):571–7.Google Scholar
- 8.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100.Google Scholar
- 12.Karimzadeh I, Vazin A, Talebnia N, Hatami-Mazinani N, Mahi-Birjand M. Performance of drug and poison information center within a Referral University hospital in southwest of Iran. Journal of Pharmaceutical Care. 2018;5(3–4):49–55.Google Scholar
- 15.Salehifar E, Ala S, Amini M, Azhdari E, Mir-Shafa F. The role of clinical pharmacists in the improvement of a pharmacovigilance system: a review of the reported adverse drug reactions during 2004-2010 in Mazandaran Province of Iran. Journal of Pharmaceutical Care. 2015;1(1):8–12.Google Scholar
- 16.Baniasadi S, Habibi M, Haghgoo R, Karimi Gamishan M, Dabaghzadeh F, Farasatinasab M, et al. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iran J Pharm Res. 2014;13(1):291–7.Google Scholar
- 20.Dashti-Khavidaki S, Khalili H, Shahverdi S, Abbasi MR, Lessan-Pezeshki M. The role of clinical pharmacy services in achieving treatment targets in Iranian haemodialysis patients. Singap Med J. 2012;53(9):599–603.Google Scholar
- 22.Tavakoli-Ardakani M, Neman B, Mehdizadeh M, Hajifathali A, Salamzadeh J, Tabarraee M. Clinical effect of individualized parenteral nutrition vs conventional method in patients undergoing autologous hematopoietic SCT. Bone Marrow Transplant. 2013;48(7):958–62. https://doi.org/10.1038/bmt.2012.280.Google Scholar
- 23.Mousavi M, Hayatshahi A, Sarayani A, Hadjibabaie M, Javadi M, Torkamandi H, et al. Impact of clinical pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial. Support Care Cancer. 2013;21(12):3441–8. https://doi.org/10.1007/s00520-013-1920-6.Google Scholar
- 26.Zolfagharian F, Ghazanfari S, Elyasi S, Iraji P, Saberi MR, Vahdati-Mashhadian N, et al. Drug utilization evaluation of albumin in a teaching hospital of Mashhad, Iran: an interventional pre-post design study. Int J Clin Pharm. 2017;39(4):704–11. https://doi.org/10.1007/s11096-017-0458-y.Google Scholar
- 28.Dastan F, Jamaati H, Emami H, Haghgoo R, Eskandari R, Hashemifard SS, et al. Reducing inappropriate utilization of albumin: the value of pharmacist-led intervention model. Iran J Pharm Res. 2018;17(3):1125–9.Google Scholar
- 29.Vazin A, Karimzadeh I, Karamikhah R, Oveisi Z, Mohseni S, Keykhaee M, et al. Clinical and economical impacts of guideline implementation by the pharmaceutical care unit for high cost medications in a referral teaching hospital. BMC Health Serv Res. 2018;18(1):815. https://doi.org/10.1186/s12913-018-3627-3.Google Scholar
- 30.Sistanizad M, Kouchek M, Miri M, Goharani R, Solouki M, Ayazkhoo L, et al. Carbapenem restriction and its effect on bacterial resistance in an intensive care unit of a teaching hospital. Iran J Pharm Res. 2013;12(3):503–9.Google Scholar
- 31.Tavakoli-Ardakani M, Ghassemi S, Alizadeh AM, Salamzadeh J, Ghadiani M, Ghassemi S. Effects of pharmacist intervention on the utilization of vancomycin in a teaching hospital. Iran J Pharm Res. 2015;14(4):1281–8.Google Scholar
- 32.Vazin A, Karimzadeh I, Zand A, Hatami-Mazinani N, Firouzabadi D. Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran. Adv Pharm Bull. 2017;7(3):391–7. https://doi.org/10.15171/apb.2017.047.Google Scholar
- 34.Abbasi Nazari M, Salamzadeh J, Hajebi G, Gilbert B. The role of clinical pharmacists in educating nurses to reduce drug-food interactions (absorption phase) in hospitalized patients. Iran J Pharm Res. 2011;10(1):173–7.Google Scholar
- 37.Abbasinazari M, Zareh-Toranposhti S, Hassani A, Sistanizad M, Azizian H, Panahi Y. The effect of information provision on reduction of errors in intravenous drug preparation and administration by nurses in ICU and surgical wards. Acta Medica Iranica. 2012;50(11):771–7.Google Scholar
- 39.Namazi S, Pourhatami S, Borhani-Haghighi A, Roosta S. Incidence of potential drug-drug interaction and related factors in hospitalized neurological patients in two Iranian teaching hospitals. Iran J Med Sci. 2014;39(6):515–21.Google Scholar
- 41.Hassani S, Eshraghi A, Hematian F, Taheri M, Sahraei Z. Role of clinical pharmacists in early detection, reporting and prevention of medication errors in a medical Ward. Journal of Pharmaceutical Care. 2017;3(3–4):54–60.Google Scholar
- 42.Haghbin S, Shahsavari S, Vazin A. Medication errors in Pediatric Intensive Care Unit: incidence, types and outcome. Trends in Pharmaceutical Sciences. 2016;2(2).Google Scholar
- 44.Fahimi F. Implementation of a clinical pharmacy education program in a teaching hospital: resident oriented documentation and intervention. Iran J Pharm Res. 2010;9(3):297–302.Google Scholar
- 45.Allameh Z, Mehrpooya M, Baniasadi S, Fahimi F. Clinical pharmacists’ interventions in a teaching hospital: types, severity, procedures, and accuracy. Research in Pharmaceutical Sciences. 2012;7(5):954.Google Scholar
- 47.Pasquale TR, Komorny KM, Letting-Mangira D, Peshek S. A pharmacist-physician antibiotic support team. P AND T. 2004;29(1):33–40.Google Scholar
- 49.Saizy-Callaert S, Causse R, Furhman C, Le Paih MF, Thebault A, Chouaid C. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect. 2003;53(3):177–82.Google Scholar
- 53.Snella KA, Sachdev GP. A primer for developing pharmacist-managed clinics in the outpatient setting. Pharmacotherapy. 2003;23(9):1153–66.Google Scholar